On the Horizon: Future Isotopes for Therapy

Saturday, March 23, 2024

9:00 AM – 11:00 AM East Coast USA Time

Location: Orange County Convention Center, W314B

CE: 2.0

ACPE Number: 0202-0000-24-060-L99-P

Number of Hours: 2

Activity Type: Knowledge

Presenter(s)

Hariprasad Gali, PhD (he/him/his)

Associate Professor
The University of Oklahoma College of Pharmacy
Oklahoma City, Oklahoma, United States

Handout

Speaker(s)

David Bauer, PhD

Research Associate
Memorial Sloan Kettering Cancer Center
New York, New York, United States

Handout

Disclosure(s):

Hariprasad Gali, PhD: No financial relationships to disclose

David Bauer, PhD: No financial relationships to disclose

We have worked with technetium-99m and iodine-131 for decades. Now there is another huge push in the development of radiopharmaceuticals. Come learn about the radionuclides that show great promise for the next generation of radioactive drugs.

Learning Objectives:

Describe the production of potentially useful isotopes for therapeutic applications (Pb-212, Ac-225, At-211, Re-188, others)
Describe the current supply chain of therapeutic isotopes and factors that may limit availability
Explain the impurity profile and processes used to separate contaminants
Discuss the potential of use in clinical trials
Describe safe handling of new radionuclides